Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 3
Review
Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
11,463 | Dovepress* | 11,463+ | 5,103 | 16,566 | |
Totals | 11,463 | 5,103 | 16,566 | ||
*Since 26 March 2010 +Since July 2016 |
View citations on Google Scholar